OYSTEIN FODSTAD has a total of 13 patent applications. Its first patent ever was published in 1992. It filed its patents most often in Australia, New Zealand and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are FODSTAD OYSTEIN, E Y LAB INC and MULTILYTE LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 6 | |
#2 | New Zealand | 3 | |
#3 | China | 2 | |
#4 | United States | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Unspecified technologies | |
#3 | Therapeutic chemical compounds | |
#4 | Medical preparations | |
#5 | Microorganisms | |
#6 | Measuring microorganism processes |
# | Name | Total Patents |
---|---|---|
#1 | Fodstad Oystein | 10 |
#2 | Engebraten Olav | 5 |
#3 | Kvalheim Gunnar | 4 |
#4 | Wang Meng Yu | 3 |
#5 | Juell Siri | 3 |
#6 | Hoifodt Hanne Kleppe | 2 |
#7 | Ree Anne Hansen | 2 |
#8 | Hovig Johannes Eivind | 2 |
#9 | Kvalbeim Gunnar | 1 |
#10 | Hoeifoedt Hanne Kleppe | 1 |
Publication | Filing date | Title |
---|---|---|
NZ336576A | Method of killing breast cancer cells with a combination of two immunotoxins | |
NZ331920A | Immuno-magnetic cell separation used in identification of genes associated with site-preferenced cancer methastasis formation | |
AU2593192A | Detection of specific target cells in specialized or mixed cell population and solutions containing mixed cell populations |